Lattice Biologics Ltd.
OTC: LBLTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Donna Medina
- Headquarters
- Belgrade, United States
- IPO year
- 2010
- Market cap
- $16.5K
- Website
- https://www.latticebiologics.com
Loading LBLTF…
Loading profile data…Frequently asked questions about LBLTF
What does Lattice Biologics Ltd. (LBLTF) do?
Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as Amnio...
Where does LBLTF trade?
Lattice Biologics Ltd. (LBLTF) trades on the Other OTC.
What sector is LBLTF in?
Lattice Biologics Ltd. (LBLTF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Lattice Biologics Ltd.?
Donna Medina is the chief executive officer of Lattice Biologics Ltd. (LBLTF).
Where is Lattice Biologics Ltd. headquartered?
Lattice Biologics Ltd. is headquartered in United States.
Does LBLTF pay a dividend?
Lattice Biologics Ltd. (LBLTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LBLTF go public?
Lattice Biologics Ltd. (LBLTF) completed its initial public offering in 2010.